This is a community-generated profile. If you would like to claim it, please .
Biolex Therapeutics Funding
$172.3M
88 rounds
Biolex Therapeutics is active in the following markets / industries: biotechnology. The company has secured funding across 8 rounds, totaling in an amount of $172.3M. Their most recent funding was raised on December 19, 2011.
Funding Rounds
U
$2400000U
$5900000D
$20000000U
$10000000D
$60000000Series DOct 2008
+1
C
$30000000Series CMay 2007
+2
B
$36000000Series BSep 2005
+1
U
$8000000UnknownJan 2005
Investors of Biolex Therapeutics
Franklin Street Partners
Tall Oaks Capital Partners
Wakefield Group
Easton Capital
OrbiMed
Dogwood Equity
Mitsui & Co. Global Investment
Bioventures Investors
The Dow Chemical Company